» Articles » PMID: 36175311

Development of a Pocket Nomogram to Predict Cancer and Disease Specific Survival After Radical Cystectomy For Bladder Cancer: The CRAB Nomogram

Abstract

Objectives: To develop an easy tool to predict cancer specific (CSS) and disease-free survival (DFS) in patients with bladder cancer treated with radical cystectomy.

Methods: Data from a consecutive series of 2395 patients with primitive or progression to muscle invasive bladder cancer (MIBC) undergone to radical cystectomy and lymph nodes dissection in 5 centers were evaluated. Using Cox proportional hazards analyses, the Cancer of the bladder risk assessment (CRAB) nomogram was generated. Accuracy of the nomogram was evaluated by Harrell's C test. Internal validation of the model was performed using 200 bootstraps.

Results: Median age was 66 (IQR 58/73) years; 612/2395 (26%) patients presented an advanced pathological stage (≥pT3a); 478/2395 (20%) presented positive lymph nodes. Overall, 729/2395 (30%) presented local or distant recurrence with a median DFS of 42 (IQR 14/89) months. Overall, 642/2395 (27%) died of bladder cancer with a median follow up of 48 (IQR 22/92) months. On univariate Cox proportional hazards analyses, age, stage, and lymph nodes density were a significant predictor of 3 and5 years CSS and DFS. Accuracy of the CRAB nomogram was 0.73 and 0.71 respectively.

Conclusion: CRAB nomogram can be a practical and easily applicable tool that may help urologists to classify the long-term CSS and DFS of patients treated with radical cystectomy and to predict the oncological outcome.

Citing Articles

A Semi-Supervised Multi-Region Segmentation Framework of Bladder Wall and Tumor with Wall-Enhanced Self-Supervised Pre-Training.

Wei J, Zheng Y, Huang D, Liu Y, Xu X, Lu H Bioengineering (Basel). 2025; 11(12.

PMID: 39768043 PMC: 11672963. DOI: 10.3390/bioengineering11121225.


Emerging Strategies in Adjuvant Immunotherapy: A Comparative Review of Bladder Cancer and Renal Cell Carcinoma Treatments.

Balli S, Bolek H, Urun Y Clin Med Insights Oncol. 2024; 18:11795549241257238.

PMID: 38827522 PMC: 11143815. DOI: 10.1177/11795549241257238.


A Novel Decision Tree Model for Predicting the Cancer-Specific Survival of Patients with Bladder Cancer Treated with Radical Cystectomy.

Sarrio-Sanz P, Martinez-Cayuelas L, Beltran-Perez A, Munoz-Montoya M, Segura-Heras J, Gil-Guillen V J Clin Med. 2024; 13(8).

PMID: 38673449 PMC: 11050271. DOI: 10.3390/jcm13082177.


Predicting individual outcomes after radical cystectomy in urothelial variants with Cancer of the Bladder Risk Assessment (COBRA) score.

Suartz C, Cordeiro M, Botelho L, Gallucci F, Cho D, de Arruda Pessoa F World J Urol. 2024; 42(1):155.

PMID: 38483580 DOI: 10.1007/s00345-024-04798-5.